Talk:COVID-19 vaccination in Canada

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Controversy section[edit]

Thank you Coolcaesar for your edits - I'm all for exploring the complicated implications of vaccine manufacturing in Canada - it's kind of a complicated past. I worry the sources currently used are slanted toward an anti-Trudeau government bias and therefore not very neutral - perhaps we could get some other opinions. I'm pinging HueMan1, Arrecife, Moxy, UmpireRay, AMT5596, LABcrabs, Johnny Au and Oceanflynn who were on the original discussion for the creation of this page. CaffeinAddict (talk) 16:04, 22 February 2021 (UTC)

  • The Lexchin article provides a rich resource with numerous useful links that could be the beginning of a section "Vaccine manufacturing in Canada".
  • This is a current and constantly changing situation that is politically charged. Rather than focusing on "criticism" and "controversy" in separate sections, it is my understanding that we present differing points of view groups by topics, where RS sources that cite both pros and cons of decisions, actions, policies, etc are grouped together. In book reviews, for example, favourable and unfavourable reviews are included in one section.
  • There is at least one source that is an Opinion piece.[1]
  • Exact dates are extremely relevant. The January 22, 2021 Opinion piece might not be helpful in depicting an accurate understanding of the situation. References to what happened 50 years ago can be used if the dates and people concerned are clearly stated.
  • This is a generalized statement: "By early 2021, the speed of Canada's deployment of COVID-19 vaccines had become the topic of widespread public discussion." If we want to keep it as a statement that will reflect accurately the narrative when read 5 years from now, it would need more references than one NYT article. We need more RS and specific dates, etc. The statement could be contextualized in terms of responses globally in all countries about the confusion surrounding the rollout. Ex, "According to a number of media sources, on this exact date [then list 3 or more RS that confirm that statement], this thing happened.[RS, RS. RS]. However, these on [this exact date] said that .....[RS, RS, RS]."
  • I think the use of the sandwich statement method is useful in dealing with controversial topics. Begin and end with the factual statements, and place misinformation in between and punctuate both with RS.
I changed this sentence with its single RS—a February 18, 2021 article in New York Times—that introduced the controversy section, "By early 2021, the speed of Canada's deployment of COVID-19 vaccines had become the topic of widespread public discussion, along with the related question of why the vaccines were not being produced in Canada" to "A February 18, 2021 article in New York Times said that Canadians were concerned about the rollout of the vaccination program." I moved it to the section on Major General's February 18 announcement about the end of shortages.Oceanflynn (talk) 17:53, 22 February 2021 (UTC)

"Major General Fortin announced on February 18, that the period in which Canada experienced limited supplies, is now over and there will be an "abundance of supplies" in the spring and summer months. This will result in a "significant scaling-up of immunization plans in provinces." Pfizer's new "locked in" delivery schedule includes 475,000 doses in February and 444,600 per week in March, according to the PHAC's vaccine distribution tracker. A February 18, 2021 article in New York Times said that Canadians were concerned about the rollout of the vaccination program."

I moved this content to a "Notes" section temporarily. Much of the content could be used in a new section "Vaccine manufacturing in Canada" using the Lexchin articles list of references as a good beginning:Oceanflynn (talk) 17:55, 22 February 2021 (UTC)
  • In a January 14, 2021, Opinion piece in the Financial Post, responding to the delay in rolling out of Canada's vaccination program, GlaxoSmithKline Canada's Paul Lucas—who served as CEO from 1995 to 2012—said that, fifty years ago, during the Liberal premiership of Pierre Trudeau, there was little interest in chemical patents. Lucas said that this policy discouraged private investment in pharmaceutical innovations in Canada and caused the Canadian pharmaceutical industry to become focused on generic drugs.
  • Health policy professor emeritus Joel Lexchin said that the publicly-owned vaccine manufacturer Connaught Laboratories was privatized under the Conservative government of prime minister Brian Mulroney (1984-1993). Connaught was then part of Sanofi Pasteur. GSK acquired the Quebec-based vaccine manufacturer IAF BioChem. Sanofi and GSK—corporations outside Canada controlled decision-making about production. The three biggest vaccine makers—GlaxoSmithKline, Merck and Sanofi—lacked the new technologies essential for the production of newer forms of vaccine, that upstarts—such as Moderna and BioNTech—had mastered and by December it was evident that they were incapable of producing an effective COVID-19 vaccine.
  • According to Lexchin, newly-elected U.S. President Joe Biden reportedly continued the controversial America First policy of predecessor Donald Trump with respect to vaccine distribution. Canada was unable to obtain vaccine doses from the United States, even though the relevant American vaccine manufacturing facilities are relatively close to the Canada–United States border: Pfizer's facility in Kalamazoo, Michigan and Moderna's facility in Portsmouth, New Hampshire (actually a Lonza Group facility producing under contract).

References[1][2][3]

References

  1. ^ a b Lucas, Paul (January 22, 2021). "Why we're not doing better on COVID vaccines". Financial Post via the National Post. Opinion. Archived from the original on February 22, 2021.
  2. ^ Lexchin, Joel (February 8, 2021). "The roots of Canada's COVID-19 vaccine shortage go back decades". The Conversation. Retrieved February 22, 2021.
  3. ^ Kuchler, Hannah; Abboud, Leila (February 15, 2021). "Why the three biggest vaccine makers failed on Covid-19". Financial Post. Retrieved February 22, 2021.

— Preceding unsigned comment added by Oceanflynn (talkcontribs)

The National Post is a centre-right source that is unsurprisingly critical of Trudeau. Johnny Au (talk/contributions) 00:37, 23 February 2021 (UTC)

One shot... two shot... three shot... blue shot[edit]

With J&J approved a bunch of the metrics are about to get screwy because of the one shot deal, in addition, it looks like most provinces are going to start applying the four month space between shots going forward - any advice on how to roll with the punches here? CaffeinAddict (talk) 16:20, 5 March 2021 (UTC)

Well we should remove the sentence saying that some provinces intend to delay the second dose. It seems they all announced the switch to 4 months now. Otherwise people who get Janssen's vaccine should be counted as a single dose, but still added to the "fully vaccinated" column. In the end, there will be X "people fully vaccinated", and less than X/2 "doses administered". To add to the confusion, some people will likely never show up for the second dose, so it will not balance anyways. --zorxd (talk) 22:26, 8 March 2021 (UTC)
As soon as J&J it'll be a big 'ole logistical mess. CaffeinAddict (talk) 01:22, 9 March 2021 (UTC)

NACI[edit]

National Advisory Committee on Immunization currently redirects here. Should this receive an article? -- 67.70.27.246 (talk) 11:01, 28 March 2021 (UTC)

Yes it should. I recommended it on the WikiProject Canada page but I really don't have time to fill something like that out. It certainly has a lot to do with the COVID-19 vaccination program right now but is definitely not exclusive to just these vaccines. CaffeinAddict (talk) 03:33, 30 March 2021 (UTC)